# Embody, Inc.

- Location (FDA's records): Norfolk, VA
- FDA decisions: 6 (2020–2025): 6 510(k) clearances
- Product codes: OWY (4), MAI (1), GAT (1)
- 510(k) review time since 2016: median 112 days, against 136 for FDA's reviews in the same codes and years (3 of 3 faster)
- Predicates its devices cite: 6 (3 its own); citations of its devices by later devices: 5 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Rotation Medical, Inc.: 2 (https://510kreport.com/company/rotation-medical)
- Arthrex, Inc.: 1 (https://510kreport.com/company/arthrex)

## Firms that cite its devices most
- Nanofiber Solutions, LLC: 1 (https://510kreport.com/company/nanofiber-solutions)
- Celestray Biotech Company, LLC.,: 1 (https://510kreport.com/company/celestray-biotech)

## Its most-cited devices
- K201572: TAPESTRY Biointegrative Implant (2020), cited by 3
- K212306: Tapestry Biointegrative Implant (2021), cited by 2

## Recent decisions
- K252647: Tapestry Biointegrative Implant (Sep 19, 2025)
- K223822: Activbraid™ (Jun 2, 2023)
- K220867: Tapestry Biointegrative Implant (May 23, 2022)
- K213958: Bioabsorbable Anchor (Apr 8, 2022)
- K212306: Tapestry Biointegrative Implant (Nov 2, 2021)
- K201572: TAPESTRY Biointegrative Implant (Oct 19, 2020)

Source page: https://510kreport.com/company/embody